Trial NCT01441414

View at ClinicalTrials.gov 
Org. Study IDs: B1131004
Secondary IDs: 2011-002190-33

Last trial update was posted on 2019-01-08

MeSH Interventions

Axitinib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Metastatic Renal Cell Carcinoma

Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

On 06 Nov 2012, based on Part I safety findings and due to strategic considerations, Pfizer decided not to open enrolment onto Part II of the study and terminated the study. For primary OM, AEs reported in ≥2 participants overall are presented.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID